The effectiveness of additional screening examinations for children and adolescents in Germany: a longitudinal retrospective cohort study.
Adolescents
Early detection
Germany
Prevention
Routine data
Statutory health insurance data
children
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
11 04 2023
11 04 2023
Historique:
received:
28
04
2022
accepted:
03
04
2023
medline:
12
4
2023
entrez:
10
4
2023
pubmed:
11
4
2023
Statut:
epublish
Résumé
Continuous medical care is particularly important in childhood and adolescence. Since there are gaps in regular care in Germany, various health insurance providers offer to cover additional examinations (e.g., U10, U11, J2) to ensure ongoing paediatrician visits. However, the question arises as to whether these examinations are effective. Thus, the main objective of this study is to determine whether participation in the U10, U11 or J2 examinations leads to more frequent and earlier diagnosis and treatment of age-specific diseases. The analyses are based on administrative claims data from a statutory health insurance fund. For each examination, an intervention group (IG) is formed and matched with a corresponding control group (CG). Descriptive analyses include proportion with diagnosis and treatment, average age of diagnosis and treatment initiation. Hypothesis testing is performed using methods appropriate to each. In addition, subgroup analyses and binominal logistic regression models are conducted. More diagnoses are detected in IG, irrespective of subgroups. Additionally, diagnoses are made slightly earlier on average in IG. In the total samples, more therapies are initiated in IG, and slightly earlier. Considering only diagnosed cases, more therapies are initiated in CG but continue to be started earlier in IG. Regression models show that participation in the examinations has the highest predictive power for detecting a diagnosis. The presence of a chronic disease and sex - male at the U10 and U11 and female at the J2 - are also significantly associated. The models further show that nationality, unemployment of parents and region also have a significant influence in some cases, whereas school-leaving qualification, vocational qualification and income of parents do not. Considering the initiation of treatment in overall samples, the models show similar results, but here the presence of a chronic illness has the highest predictive power. The results indicate that participation in the examinations leads to significantly more diagnoses and, in the overall samples, significantly more treatments. In addition, diagnoses were made somewhat earlier and therapies were initiated somewhat earlier. In the future, it would be useful to investigate the U10, U11 and J2 examinations over a longer time horizon to determine whether the statistically significant difference found is also clinically relevant, i.e., earlier diagnosis and initiation of therapy lead to prevention of manifestation or progression of the diagnosed diseases and to avoidance of secondary diseases. German Clinical Trials Register (DRKS), DRKS-ID: DRKS00015280. Prospectively registered on 18 March 2019.
Sections du résumé
BACKGROUND
Continuous medical care is particularly important in childhood and adolescence. Since there are gaps in regular care in Germany, various health insurance providers offer to cover additional examinations (e.g., U10, U11, J2) to ensure ongoing paediatrician visits. However, the question arises as to whether these examinations are effective. Thus, the main objective of this study is to determine whether participation in the U10, U11 or J2 examinations leads to more frequent and earlier diagnosis and treatment of age-specific diseases.
METHODS
The analyses are based on administrative claims data from a statutory health insurance fund. For each examination, an intervention group (IG) is formed and matched with a corresponding control group (CG). Descriptive analyses include proportion with diagnosis and treatment, average age of diagnosis and treatment initiation. Hypothesis testing is performed using methods appropriate to each. In addition, subgroup analyses and binominal logistic regression models are conducted.
RESULTS
More diagnoses are detected in IG, irrespective of subgroups. Additionally, diagnoses are made slightly earlier on average in IG. In the total samples, more therapies are initiated in IG, and slightly earlier. Considering only diagnosed cases, more therapies are initiated in CG but continue to be started earlier in IG. Regression models show that participation in the examinations has the highest predictive power for detecting a diagnosis. The presence of a chronic disease and sex - male at the U10 and U11 and female at the J2 - are also significantly associated. The models further show that nationality, unemployment of parents and region also have a significant influence in some cases, whereas school-leaving qualification, vocational qualification and income of parents do not. Considering the initiation of treatment in overall samples, the models show similar results, but here the presence of a chronic illness has the highest predictive power.
CONCLUSION
The results indicate that participation in the examinations leads to significantly more diagnoses and, in the overall samples, significantly more treatments. In addition, diagnoses were made somewhat earlier and therapies were initiated somewhat earlier. In the future, it would be useful to investigate the U10, U11 and J2 examinations over a longer time horizon to determine whether the statistically significant difference found is also clinically relevant, i.e., earlier diagnosis and initiation of therapy lead to prevention of manifestation or progression of the diagnosed diseases and to avoidance of secondary diseases.
TRIAL REGISTRATION
German Clinical Trials Register (DRKS), DRKS-ID: DRKS00015280. Prospectively registered on 18 March 2019.
Identifiants
pubmed: 37038135
doi: 10.1186/s12887-023-03988-1
pii: 10.1186/s12887-023-03988-1
pmc: PMC10088104
doi:
Banques de données
DRKS
['DRKS00015280']
Types de publication
Clinical Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
164Informations de copyright
© 2023. The Author(s).
Références
Arch Dis Child. 2020 Aug 11;:
pubmed: 32788200
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Apr;57(4):455-63
pubmed: 24658675
JAMA. 2017 Jun 20;317(23):2417-2426
pubmed: 28632874
BMC Health Serv Res. 2020 Mar 16;20(1):217
pubmed: 32178662
Am J Ophthalmol. 2018 Oct;194:xviii-xxiii
pubmed: 30059651
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 May-Jun;50(5-6):686-700
pubmed: 17514453
PLoS One. 2019 Mar 13;14(3):e0213700
pubmed: 30865713
JAMA Netw Open. 2021 Apr 1;4(4):e215335
pubmed: 33843998
PLoS One. 2017 Jul 3;12(7):e0180410
pubmed: 28671981
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Jul;57(7):878-91
pubmed: 24950837
Klin Padiatr. 2017 Jan;229(1):2-13
pubmed: 27975344
J Adolesc Health. 2017 Mar;60(3):249-260
pubmed: 28011064
Dtsch Arztebl Int. 2011 Mar;108(11):180-6
pubmed: 21475566
J Health Monit. 2017 Dec 13;2(4):42-61
pubmed: 37168128
Int J Qual Health Care. 2021 Feb 8;33(1):
pubmed: 33449077
Dtsch Med Wochenschr. 2017 Apr;142(8):e42-e50
pubmed: 28431439
BMC Psychiatry. 2016 Jul 26;16:263
pubmed: 27455845
CMAJ. 2017 Feb 27;189(8):E310-E316
pubmed: 28246224
Internist (Berl). 2015 Oct;56(10):1107-13
pubmed: 26358949
J Health Monit. 2018 Dec 12;3(4):62-70
pubmed: 35586144
J Speech Lang Hear Res. 2004 Aug;47(4):924-43
pubmed: 15324296
Gesundheitswesen. 2016 Mar;78(3):e6-13
pubmed: 25531157
Health Policy. 2016 Feb;120(2):213-26
pubmed: 26826756